With Strategyn’s help, we introduced 19 new angioplasty balloon products–all of which became number 1 or 2 in the market. Our market share grew from 2% to over 20%. In addition, we reprioritized resources to become the first to market with the stent. It was the fastest growing medical device in history and became a $1 billion industry in less than two years.

Strategyn helped us understand customer needs for a product that didn’t yet exist. They also helped us formulate a growth strategy that led us to a position of market leadership. If the big, well-established companies in this space had applied Strategyn’s outcome-driven concepts, they could have dominated. Instead, they were all disrupted.

We were a business facing a potential crisis. Using ODI, we were able to discover many new growth opportunities, pull together a valuable offering and reframe our marketing message around a PC lifecycle management offering. In a market under immense price pressure, Strategyn helped us grow a struggling business.

Strategyn helped us understand that our product was poorly positioned and failed to get important parts of the job done. They helped us identify and fill the gaps, which we accomplished with targeted development and M&A activity. The project had a significant financial impact on the business. We have had similar successes with other ODI projects.

We started to see results from our new messaging and positioning strategy almost immediately. It contributed to an outstanding year. In the end, we grew greater than 30% and the ODI process played a significant role in that growth. Every one of our products had double-digit growth. We far outpaced our competitors.

I want to thank the Strategyn team for its contributions on this journey. Your teams had a huge positive effect on me, our teams and on MDCO. We learned so much working with you and I believe the outputs, not to mention the mindset you helped us shape, is groundbreaking in an industry that traditionally struggles with innovation management.

Your Outcome-Driven Innovation process is right on point—and we benefited from the approach and your guidance enormously. It drove our technology selection, our development priorities, manufacturing strategies and commercial planning.